UBS AM’s Aktis Oncology AKTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.44K Buy
+331
New +$8.06K ﹤0.01% 3873

Other funds holding AKTS

UBS AM's AKTS Position: Q3 2026 in Review

UBS AM opened a new position in Aktis Oncology (AKTS) in Q3 2026: 331 shares worth $6.44K. The stake represents ﹤0.01% of the portfolio and ranks #3873 among its holdings.

105 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.

  • UBS AM held 331 shares of Aktis Oncology worth $6.44K as of Q3 2026.
  • Aktis Oncology was a new UBS AM position in Q3 2026.
  • Aktis Oncology made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3873 holding.
  • 105 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.